Once-daily dose of budesonide aqueous nasal spray 128 g is efficacious primary treatment with rapid onset in nasal polyps.

被引：0
作者：
Jankowski, R [1 ]
Bonfils, P [1 ]
Castillo, L [1 ]
Gilain, L [1 ]
Prades, JM [1 ]
Strunski, V [1 ]
机构：
[1] Hop Cent, Nancy, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1999年 / 103卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
635
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 43 条
[31]   Long-term safety of fluticasone furoate nasal spray (FFNS) 110 μg once-daily in adults and adolescents with perennial allergic rhinitis [J].
Rosenblut, A. ;
Bardin, P. ;
Fokkens, W. ;
Faris, M. ;
Wu, W. ;
Caldwell, M. ;
Rinia, B. .
ALLERGY, 2007, 62 :227-227
[32]   Fluticasone furoate nasal spray (FFNS) 110Gμ once-daily is effective in seasonal allergic rhinitis (SAR) caused by grass pollen [J].
Fokkens, W. ;
Jogi, R. ;
Sidorenko, I. ;
Sitkauskiene, B. ;
van Tongeren, J. ;
Faris, M. ;
Ellsworth, A. ;
Caldwell, M. .
ALLERGY, 2007, 62 :134-134
[33]   LACK OF HYPOTHALAMIC-PITUITARY-ADRENAL AXIS SUPPRESSION WITH ONCE-DAILY OR TWICE-DAILY BECLOMETHASONE DIPROPIONATE AQUEOUS NASAL SPRAY ADMINISTERED TO PATIENTS WITH ALLERGIC RHINITIS [J].
BRANNAN, MD ;
HERRON, JM ;
REIDENBERG, P ;
AFFRIME, MB .
CLINICAL THERAPEUTICS, 1995, 17 (04) :637-647
[34]   Once-daily fluticasone furoate* nasal spray (FFNS) is effective for the treatment of seasonal allergic rhinitis (SAR) caused by ragweed *LISAN-approved name [J].
Kaiser, H. B. ;
Naclerio, R. ;
Given, J. ;
Philpot, E. ;
Toler, T. ;
Ellsworth, A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) :S232-S232
[35]   Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily and twice daily in the treatment of bilateral nasal polyposis:: a placebo-controlled randomized study in adult patients [J].
Penttilä, M ;
Poulsen, P ;
Hollingworth, K ;
Holmström, M .
CLINICAL AND EXPERIMENTAL ALLERGY, 2000, 30 (01) :94-102
[36]   Efficacy and safety of triamcinolone acetonide aqueous nasal spray 110 μg once daily in children aged 2-5 years with perennial allergic rhinitis [J].
Weinstein, S. F. ;
Georges, G. ;
Qaqundah, P. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) :A89-A89
[37]   Efficacy of a novel enhanced-affinity glucocorticoid on ocular symptoms, fluticasone furoate nasal spray (FFNS) 110 μg once-daily, in grass pollen-sensitive patients [J].
Sidorenko, I. ;
Sitkauskiene, B. ;
Jogi, R. ;
Fokkens, W. ;
van Tongeren, J. ;
Faris, M. ;
Ellsworth, A. ;
Caldwell, M. .
ALLERGY, 2007, 62 :134-135
[38]   The effect on growth of 6 month's treatment with triamcinolone acetonide aqueous nasal spray 110 μg once daily in children aged 2-5 years with perennial allergic rhinitis [J].
Ratner, P. ;
Georges, G. ;
Kerwin, E. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) :S56-S56
[39]   Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis [J].
R. Giger ;
P. Pasche ;
C. Cheseaux ;
L. Cantini ;
A. Rossetti ;
B. Landis ;
J. Lacroix .
European Archives of Oto-Rhino-Laryngology, 2003, 260 :135-140
[40]   Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis [J].
Giger, R ;
Pasche, P ;
Cheseaux, C ;
Cantini, L ;
Rossetti, A ;
Landis, BN ;
Lacroix, JS .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (03) :135-140
12345